RCTJadad 3/5RandomizedDouble-BlindPlacebo-Controlled

NMN and Muscle Recovery: What a New BFR Training Trial Reveals About This Popular Longevity Supplement

Journal of the International Society of Sports NutritionFebruary 18, 2026Vol. 23 (1)

Summary

NMN (nicotinamide mononucleotide) has become one of the hottest anti-aging supplements on the market, marketed for boosting NAD+ levels, energy, and healthy aging. But a new randomized, double-blind, placebo-controlled crossover trial from Taiwan asks a different question: what does NMN actually do to your muscles right after a hard workout?

Researchers recruited 11 healthy, untrained young men (average age 23) and had each complete two separate testing rounds — one after 7 days of NMN (1200 mg/day, split into four 300 mg doses) and one after 7 days of an identical-looking placebo — with a 3-week washout between rounds. Each round ended with a blood flow restriction (BFR) resistance exercise session: cuffs inflated to 180 mmHg on the thighs for three 5-minute rounds, followed immediately by four sets of heavy back squats (70% of 1-rep max). BFR training deliberately amplifies muscle damage and inflammation, making it an ideal stress test for an "anti-inflammatory" supplement. Muscle biopsies were taken before exercise, immediately after, and 24 hours later to track what was actually happening inside the muscle tissue.

The results were a mixed bag. On one hand, NMN lived up to its anti-inflammatory billing: it blunted the post-exercise spike in TNF-α (an inflammatory signaling molecule) by nearly half compared to placebo, and it prevented the usual rise in IL-10 (a "resolution" cytokine) entirely. On the other hand, this dampened inflammatory response came with trade-offs. Muscle cell infiltration — immune cells rushing in to clear damaged tissue — normally spikes and then resolves within 24 hours; with NMN, resolution was delayed, with infiltration still elevated at the 24-hour mark. NMN also blunted the rise of p21 mRNA, a marker linked to muscle cells maturing after damage, suggesting slower muscle differentiation.

The most striking finding involves mitochondria — the "energy factories" inside cells. Normally, BFR exercise triggers a 171% increase in muscle mitochondrial content by 24 hours post-exercise, an adaptation widely considered beneficial for endurance and metabolic health. NMN completely blocked this increase. Using fluorescent imaging, the researchers discovered why: neutrophils (a type of infiltrating immune cell) appear to physically donate mitochondria to damaged muscle fibers as part of the repair process — essentially "restocking" muscle cells with fresh mitochondrial power plants after ischemic exercise damage. By dialing down the inflammatory/immune response, NMN appears to interrupt this cell-to-cell mitochondrial transfer.

Bottom line: NMN's anti-inflammatory effects are real and measurable in human muscle tissue, but this small, exploratory study suggests that suppressing exercise-induced inflammation isn't uniformly "good" — it may come at the cost of blocking part of the muscle's natural repair and mitochondrial renewal machinery, at least in the acute 24-hour window after intense training.

Sources: Anti-inflammatory effects of NMN in human skeletal muscle after BFR-exercise (PMC), NutraIngredients coverage

What This Means For You

If you're taking NMN around intense training — especially high-inflammation methods like BFR training, heavy eccentric work, or new-to-you exercise — this study suggests timing matters more than the marketing implies. The dose used here (1200 mg/day, split into four 300 mg capsules with meals and before bed) sits within the range shown safe in other human trials (300–1250 mg/day), but it's well above the ~250 mg/day found in most commercial single-serving products, so check labels against this if you're trying to replicate the protocol.

For general recovery and anti-inflammatory purposes, this data supports NMN doing what it claims at the muscle-tissue level — not just in blood biomarkers. But if your goal is maximizing training adaptations like mitochondrial biogenesis (relevant for endurance athletes, BFR trainees, or anyone chasing metabolic conditioning), taking NMN in the immediate window around a damaging workout may blunt part of the adaptive response you're training for. Athletes focused on hypertrophy or endurance gains might consider avoiding NMN on hard training days, or separating dosing from the workout window, until more research clarifies optimal timing — the study authors themselves flagged this as an open question.

People recovering from injury, overtraining, or illness — where dialing down excess inflammation is the priority rather than maximizing training adaptation — may be the better-suited audience for peri-exercise NMN use. As with any supplement claim, "anti-inflammatory" isn't automatically better: inflammation is a necessary signal for adaptation, and blunting it indiscriminately (as seen with high-dose NSAIDs and hypertrophy) can undercut the very training effect you want. Given the tiny sample (11 men), treat this as hypothesis-generating rather than a reason to change your stack today — talk to a sports medicine professional if you're combining NMN with a serious BFR or strength program.

Important Considerations

This study is small (11 healthy young men, ages 20–30) and used a crossover design, which is statistically efficient but still limits how confidently results generalize to women, older adults, trained athletes, or people with existing inflammatory or metabolic conditions — all groups excluded here. Four of the original 15 volunteers dropped out before starting (scheduling conflicts, not side effects), and the Jadad quality score (3/5) reflects that randomization and blinding were reported but not described in full methodological detail.

The 1200 mg/day dose and 4x-daily timing schedule is a specific research protocol, not necessarily what's on a store shelf — commercial NMN capsules vary widely in dose, purity, and delivery form (capsule, sublingual, liposomal), and this trial cannot tell you whether lower everyday doses produce the same effects. Also note: many outcomes here are mRNA (gene expression) and imaging-based mechanistic markers, not hard performance outcomes like strength, soreness, or actual recovery time — so we don't yet know if blunted mitochondrial gains or delayed cell resolution translate to worse (or better) real-world training outcomes.

The authors are explicit that they don't know whether blocking the mitochondrial increase is a "good" or "bad" thing metabolically — animal research has shown lower mitochondrial content can sometimes extend longevity, so more isn't automatically better. No formal adverse event tracking was reported, and this trial was funded by a public science council (not industry), though it did use a commercial NMN ingredient brand. Watch for marketing claims that generalize "NMN reduces inflammation" into blanket recovery or anti-aging claims — this trial specifically found a double-edged effect, not a purely beneficial one. If you have an inflammatory condition, are on medication, or are pregnant/breastfeeding, consult a healthcare provider before starting NMN, as this trial excluded all such individuals.

Terms Explained

NMN (nicotinamide mononucleotide)A naturally occurring compound found in foods like edamame and broccoli that the body converts into NAD+, a molecule essential for cellular energy production and repair.

NAD+A coenzyme found in every cell that fuels energy metabolism and DNA repair; levels naturally decline with age, which is why NAD+-boosting supplements like NMN are popular in anti-aging circles.

Blood flow restriction (BFR) trainingAn exercise technique using an inflated cuff to partially restrict blood flow to a limb during or before exercise, amplifying muscle stress and hypertrophy signals even at lower training loads.

TNF-α (tumor necrosis factor-alpha)An early-response inflammatory signaling molecule released by immune cells that helps clear damaged tissue after exercise-induced muscle injury.

IL-10 (interleukin-10)An anti-inflammatory signaling molecule released later in the recovery process that helps wind down inflammation and support tissue regeneration.

Mitochondrial contentThe amount of mitochondria (the cell's energy-producing structures) present in muscle tissue; higher content is generally linked to better endurance and metabolic health.

Crossover trialA study design where each participant receives both the treatment and the placebo at different times, allowing them to serve as their own control for more statistically powerful comparisons.

Double-blind, placebo-controlledA study design where neither participants nor researchers know who received the real supplement versus a fake (placebo) one, reducing bias in the results.

p21 mRNAA genetic marker that rises as muscle cells stop dividing and mature into repaired tissue, used here as a signal of muscle cell differentiation during recovery.

NeutrophilsA type of white blood cell that rushes to damaged tissue first during inflammation to clear debris and, as this study suggests, may also donate mitochondria to injured muscle cells.

Technical Study Details

Study Design

Total Score

JADAD Quality Assessment

/ 5

評価詳細

Randomization

0 / 2

Is the study described as randomized?

Yes+1

Rationale: The article explicitly describes the study as "randomized" in the abstract and states participants "were randomly assigned" in the Study design section of the Methods, satisfying the Jadad criterion for mentioning randomization.

Is the method of randomization described and appropriate?

No-1

Rationale: The article states participants were "randomly assigned in a balanced order," confirming randomization occurred, but it does not describe the specific method used (e.g., computer-generated random numbers, random number table, coin toss, sealed envelopes). Without a description of the actual randomization technique, the appropriateness of the method cannot be verified, so per Jadad scale criteria this should be scored "no."

Blinding

2 / 2

Is the study described as double-blind?

Yes+1

Rationale: The Study design section of the Materials and methods explicitly states the trial was conducted as a "double-blind, placebo-controlled crossover study," directly meeting the criterion for this item.

Is the method of blinding described and appropriate?

Yes+1

Rationale: The article explicitly describes the double-blind method: both NMN and Placebo were delivered as gelatin capsules identical in appearance, size, and color, and both experimenters and participants were blinded to group assignment throughout the study. This is an appropriate blinding method (matched placebo capsules indistinguishable from the active supplement), satisfying the Jadad criterion for appropriate blinding.</rationale> </invoke>

Dropouts/Withdrawals

1 / 1

Is there a description of dropouts and withdrawals?

Yes+1

Rationale: The article explicitly states both the number of withdrawals (4 out of 15 initially enrolled) and the reason (scheduling conflicts), satisfying the Jadad criterion for description of withdrawals/dropouts. This is reiterated in the Results section referencing a flow chart (Figure 1). While this is a crossover trial where all 11 completing participants underwent both conditions (rather than separate parallel groups), the number and reason for participant withdrawal from the study is clearly documented.</rationale> </invoke>

Study Population

Sample Size11

Age RangeMean: 22.8 years

ConditionHealthy untrained young men undergoing blood flow restriction-preconditioned resistance exercise (BFR-exercise)-induced skeletal muscle damage/inflammation

Inclusion Criteria

Male
Between 20 and 30 years old
Non-athletic, young, prior weight-training experience from physical education classes

Interventions

β-Nicotinamide mononucleotide (NMN)

Treatment

Dose1200 mg/day (300 mg x 4 capsules/day)

Frequency4 times daily (after each of 3 main meals and before bedtime)

Duration7 days (6 days prior to BFR-exercise plus the day of exercise/24-h recovery)

Routeoral

Placebo (cornstarch)

Control

Dose1200 mg/day (300 mg x 4 capsules/day)

Frequency4 times daily (after each of 3 main meals and before bedtime)

Duration7 days (6 days prior to BFR-exercise plus the day of exercise/24-h recovery)

Routeoral

Blood flow restriction (BFR) resistance exercise challenge

Treatment

Outcomes

Outcome	Type	Effect	p-value
Nucleated cell infiltration	Primary	-	0.09
Mitochondrial content in skeletal muscle	Primary	2.60	0.02Significant
TNF-α mRNA expression	Secondary	-	<0.05Significant
IL-10 mRNA expression	Secondary	-	<0.05Significant
p21 mRNA expression	Secondary	-	<0.05Significant
Rating of Perceived Exertion (RPE)	Secondary	-	-
Muscle necrosis area	Secondary	-	-

Safety

Dropout Rate26.7%

No formal adverse event reporting was described in the article. The 4 dropouts occurred prior to intervention due to scheduling conflicts, not adverse events.

Conclusion

NMN supplementation suppressed BFR-exercise-induced inflammatory signaling in human skeletal muscle (attenuated TNF-α and IL-10 mRNA responses) but delayed resolution of nucleated cell infiltration and blunted the rise in p21 mRNA (delayed myogenic differentiation). Immunofluorescence revealed that infiltrating phagocytes (MPO+ cells) carry substantially more mitochondria than myofiber cytoplasm and preferentially accumulate in disrupted/necrotic myofiber regions, suggesting damage-induced mitochondrial transfer from bone marrow-derived immune cells (e.g., neutrophils) to stressed myofibers. NMN supplementation also abolished the normal BFR-exercise-induced increase (+171%) in muscle mitochondrial content, suggesting that its anti-inflammatory action interferes with this phagocyte-to-myofiber mitochondrial transfer/replenishment process.

Limitations

Unclear whether the lack of mitochondrial increase in BFR-exercised muscle with NMN supplementation represents a favorable or malignant metabolic outcome for humans.
The type of invading nucleated cell population affected by NMN was not identified in this study.
Whether separating NMN supplementation timing (e.g., 12 h before/after BFR-exercise) could produce a more metabolically balanced outcome for long-term human health remains untested.